What does this research mean for the field?

N-EVs reduce myocardial injury by delivering miR-16-5p, which suppresses CYP1B1-mediated PANoptosis, showing potential for AMI therapy. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim is to explore how circulating extracellular vesicles (EVs) can regulate PANoptosis in myocardial tissue through miR-16-5p.

February 13, 2026Open Access

Circulating EVs are involved in myocardial tissue PANoptosis regulation by delivering miR-16-5p to treat myocardial injury

Key Result

N-EVs delivering miR-16-5p reduce myocardial injury by suppressing CYP1B1-mediated PANoptosis, offering therapeutic potential for acute myocardial infarction.

Key Points

The aim is to explore how circulating extracellular vesicles (EVs) can regulate PANoptosis in myocardial tissue through miR-16-5p.
Examined the role of circulating EVs in myocardial injury
Analyzed the delivery of miR-16-5p to target cells
Monitored suppression of CYP1B1-mediated PANoptosis in vitro and in vivo
Circulating EVs significantly reduced myocardial injury
Delivery of miR-16-5p lowered CYP1B1 levels
Suggested EV-based therapies could aid in cardiac repair and fibrosis prevention

Structured PICO

Do N-EVs delivering miR-16-5p mitigate myocardial injury in preclinical models of acute myocardial infarction?

Population

Preclinical models of acute myocardial infarction (AMI) / myocardial injury (specific model not stated)

Intervention

N-EVs (extracellular vesicles) delivering miR-16-5p

Outcome

Mitigation of myocardial injury and suppression of CYP1B1-mediated PANoptosissurrogate

N-EVs delivering miR-16-5p show therapeutic potential for acute myocardial infarction by suppressing CYP1B1-mediated PANoptosis and promoting cardiac repair.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

N-EVs mitigate myocardial injury by delivering miR-16-5p to suppress CYP1B1-mediated PANoptosis, highlighting their role in intercellular communication and therapeutic potential for AMI. This study provides insights into EV-based strategies for cardiac repair and fibrosis prevention.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Zhang et al. (Mon,) reported a other. N-EVs delivering miR-16-5p reduce myocardial injury by suppressing CYP1B1-mediated PANoptosis, offering therapeutic potential for acute myocardial infarction.

synapsesocial.com/papers/698ebedd85a1ff6a93016262 https://doi.org/https://doi.org/10.1016/j.intimp.2026.116272

Bookmark

View Full Paper